• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov29
Citi Rates Rhythm Pharmaceuticals 'Buy'
08:39
Nov24
Chief HR Officer of Rui Si Pharmaceutical Disposes of Company's Common Stock
21:16
Nov10
Rhythm Pharmaceuticals Presents Setmelanotide Phase 3 Trial Data
12:01
H.C. Wainwright Analyst Maintains Buy Rating on Rhythm Pharmaceuticals Stock
11:32
Nov7
Rhythm Pharmaceuticals' IMCIVREE® New Drug Application Review Extended to March 20, 2026
12:30
Nov5
Analyst Gives Strong Buy Rating to Rhythm Pharmaceuticals
09:51

Schedules & Filings

Schedules
Filings
Nov4
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 51.3 M, Net Income -54.28 M, EPS -0.8191

Aug5
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 48.5 M, Net Income -47.98 M, EPS -0.7534

May7
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 32.7 M, Net Income -50.82 M, EPS -0.8059

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
SEVNR
0.0280
+218.18%
+0.019
SMX
141.000
+141.07%
+82.510
PLRZ
14.500
+104.51%
+7.410
PMI
3.690
+82.67%
+1.670
SNCR
8.710
+64.34%
+3.410
PMCB
1.210
+54.22%
+0.425
QCLS
6.920
+48.18%
+2.250
ANPA
21.860
+40.67%
+6.320
HYNE
14.000
+40.00%
+4.000
ASTX
46.070
+36.50%
+12.320
View More